They have got themselves in the BP’s eyes from an early stage.
Also, the Lilly deal is means Aktis does the preclinical and Lilly will take over from phase 1. Is Lilly acting desperate?
CU6 - Media and Industry News, page-134
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$5.57 |
Change
0.480(9.43%) |
Mkt cap ! $1.735B | |||
| Open | High | Low | Value | Volume |
| $5.20 | $5.57 | $5.16 | $14.63M | 2.711M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6146 | $5.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.60 | 6194 | 4 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| CU6 (ASX) Chart |